ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      0.00%
      US Tech 100
      19,220.00
      1.11%
      Dow Jones
      40,287.53
      0.00%
      Brent Oil
      81.205
      -1.31%
      Bitcoin
      67,687.58
      -0.69%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Maravai LifeSciences Holdings Inc (MRVI) Quote

      Maravai LifeSciences Holdings Inc

      Maravai LifeSciences Holdings Inc (MRVI)

      NASDAQ
      8.64
      -0.36
      (-4.00%)
      Closed July 19 4:00PM
      Delayed by 15 minutes
      8.64
      0.00
      ( 0.00% )
      Pre Market: 8:33AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      8.64
      Bid
      8.38
      Ask
      10.41
      Volume
      46
      0.00 Day's Range 0.00
      4.52 52 Week Range 12.56
      Market Cap
      2.177B
      Previous Close
      8.64
      Open
      -
      Last Trade
      1
      @
      8.67
      Last Trade Time
      08:08:04
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      2,178,132
      Shares Outstanding
      251,924,898
      Dividend Yield
      -
      PE Ratio
      -18.29
      Earnings Per Share (EPS)
      -0.47
      Revenue
      292.23M
      Net Profit
      -119.03M

      About Maravai LifeSciences Holdings Inc

      Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRVI. The last closing price for Maravai LifeSciences was $8.64. Over the last year, Maravai LifeSciences shares have traded in a share price range of $ 4.52 to $ 12.56.

      Maravai LifeSciences currently has 251,924,898 shares outstanding. The market capitalization of Maravai LifeSciences is $2.18 billion. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -18.29.

      MRVI Latest News

      More News

      Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024

      SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators...

      July 10 2024
      GlobeNewswire Inc.

      Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report

      - Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues...

      July 02 2024
      GlobeNewswire Inc.

      Form 144 - Report of proposed sale of securities

      May 28 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      May 28 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      May 28 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 24 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 24 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 24 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 24 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 24 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.36-499.498.5516686148.98032964CS
      41.3718.84456671257.279.496.6725917677.62135268CS
      120.8811.34020618567.7611.5556.6721781328.53267466CS
      262.3737.79904306226.2711.5555.04524472887.85563434CS
      52-3.83-30.71371291112.4712.564.5224812327.96467879CS
      156-32.33-78.911398584340.9763.554.52204069518.81572152CS
      260-22.47-72.227579556431.1163.554.52191606720.86683285CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MIRAMIRA Pharmaceuticals Inc
      $ 1.01
      (46.63%)
      		9.2M
      SERVServe Robotics Inc
      $ 10.21
      (35.23%)
      		23.9M
      RRRichtech Robotics Inc
      $ 1.88
      (27.89%)
      		13.25M
      NCPLNetcapital Inc
      $ 0.1325
      (27.40%)
      		35.37M
      DBVTDBV Technologies SA
      $ 1.01
      (20.24%)
      		342.03k
      HUBCWHub Cyber Security Ltd
      $ 0.0121
      (-47.39%)
      		1.67k
      XCURExicure Inc
      $ 0.3948
      (-26.22%)
      		401.45k
      SNTGSentage Holdings Inc
      $ 2.0205
      (-18.53%)
      		26.87k
      PIRSPieris Pharmaceuticals Inc
      $ 6.00
      (-17.24%)
      		10
      BCBPBCB Bancorp Inc
      $ 10.20
      (-16.53%)
      		628
      NCPLNetcapital Inc
      $ 0.1325
      (27.40%)
      		35.37M
      SERVServe Robotics Inc
      $ 10.21
      (35.23%)
      		23.9M
      RRRichtech Robotics Inc
      $ 1.88
      (27.89%)
      		13.25M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.229
      (6.22%)
      		9.41M
      MIRAMIRA Pharmaceuticals Inc
      $ 1.01
      (46.63%)
      		9.2M

      MRVI Discussion

      View Posts
      Monksdream Monksdream 5 months ago
      MRVI No 2 on the Barchart 100
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0
      Monksdream Monksdream 5 months ago
      Early Barchart 100
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0
      crudeoil24 crudeoil24 3 years ago
      Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
      7:24 am ET March 3, 2021 (MarketWatch)
      👍️0
      crudeoil24 crudeoil24 3 years ago
      Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

      Mar 3, 2021 7:35a ETBenzinga Stock Analysis
      👍️0
      crudeoil24 crudeoil24 3 years ago
      Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
      👍️0

      Your Recent History

      NASDAQ
      MRVI
      Maravai LifeSciences
      Delayed Upgrade Clock